Abiopharma

General Announcement: Section 1446(f) Qualified Notice For 1 Jul 2026 to 30 Sep 2026

General Announcement: MONTHLY UPDATE ON CREDITORS VOLUNTARY WINDING-UP OF SUBSIDIARY

Response to SGX Queries:

Change in holdings of interested parties/officers

General Announcement: ADVANCE NOTICE: TOKU H1 2026 EARNINGS CALL

General Announcement: Press Release - Shipment of Metalens Smartphone & AI Smart Glasses to Customers for Evaluation

Mandatory Cash Dividend/ Distribution:

General Announcement: Next Day Disclosure Return

General Announcement: CHANGE OF SHARE REGISTRAR AND PLACE WHERE THE REGISTER OF MEMBERS AND INDEX IS KEPT

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest of Director and Chief Executive Officer - Ravinder Sajwan